MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2025 International Congress

    Optimizing deep brain stimulation programming settings for patients with stimulation-induced dyskinesias in Parkinson’s disease

    S. Kaul, J. Deng, D. Fletcher, L. Colantonio, A. Memon, MC. Moreno-Escobar, A. Murray, G. Adams, J. Frey (Morgantown, USA)

    Objective: To assess the impact of Deep Brain Stimulation (DBS) parameters on stimulation-induced dyskinesias (SID) in patients with Parkison’s Disease (PD). Background: SID resemble levodopa-induced…
  • 2025 International Congress

    Low-frequency pallidum evoked potential dynamics as a prospective biomarker for Parkinson’s disease

    B. Mohanty, N. Perera, K. O'Neill Iii, S. Alberico, M. Hill, D. Bauer, B. Pobiel, J. Froula, D. Darrow, M. Park, J. Wang, L. Johnson, J. Aman, J. Vitek (Minneapolis, USA)

    Objective: Characterize low-frequency evoked potential (EP) activity induced by deep brain stimulation (DBS) in the internal globus pallidus (GPi) and how the EP dynamics modulate…
  • 2025 International Congress

    Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.

    C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Rivera-Quintero (Cali, Colombia)

    Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…
  • 2025 International Congress

    Rapid Neurologic Decline after Subthalamic Nucleus Deep Brain Stimulation in Leucine-Rich Repeat Kinase 2 Parkinson’s disease (LRRK2-PD)

    T. Haddad, M. Rochman, TW. Liang (Phialdelphia, USA)

    Objective: To describe the clinical outcomes of two unrelated patients with LRRK2-PD who experienced rapid neurologic decline following subthalamic nucleus deep brain stimulation (STN-DBS). Background:…
  • 2025 International Congress

    Symptomatic Peri-Lead Oedema After Bilateral Subthalamic Nucleus Deep Brain Stimulation Surgery- Not All Cases Are Self-Limiting: A Case Series

    SS. Idris, O. Parras Granero, A. Chari, M. Krueger, H. Akram, J. Hyam, T. Foltynie, L. Zrinzo, P. Limousin (London, United Kingdom)

    Objective: To share 3 cases presented with seizure and encephalopathy after bilateral subthalamic nucleus deep brain stimulation surgery for Parkinson’s disease that requires removal of…
  • 2025 International Congress

    DBS Withdrawal Syndrome in Advanced Parkinson’s Disease: A Case Series

    H. Omercikoglu Ozden, S. Irmak, D. Gunal (İstanbul, Turkey)

    Objective: Deep Brain Stimulation (DBS) is a widely used neuromodulation therapy for managing motor complications in advanced Parkinson’s disease (PD). However, abrupt cessation of DBS,…
  • 2025 International Congress

    Basal Ganglia Neurophysiological Activity Associated with Depression in Parkinson’s Disease

    K. Johnson, P. Coutinho, L. Kenney, J. Wong, J. Hilliard, K. Foote, D. Bowers, G. Pontone, C. de Hemptinne (Gainesvile, USA)

    Objective: The objective of this study was to identify neurophysiological activity in the basal ganglia associated with depression in patients with Parkinson’s disease (PD) undergoing…
  • 2025 International Congress

    Does 10-year STN-DBS impact the natural progression of Parkinsons Disease? A Multicenter Retrospective Controlled Observational Study

    A. Gozzi, S. Convenga, L. Romito, F. Bove, F. Cavallieri, E. Scelzo, R. Cilia, R. Eleopra, V. Fraix, A. Castrioto, AR. Bentivoglio, C. Piano, I. Isaias, A. Priori, M. Sensi, D. Azzolina, P. Pellissier, S. Meoni, E. Moro (Grenoble, France)

    Objective: to evaluate the long-term risk of wheelchair confinement and motor function in Parkinson’s disease (PD) patients undergoing subthalamic deep brain stimulation (STN-DBS), compared to…
  • 2025 International Congress

    Joint Prediction of Motor and Non-motor Deep Brain Stimulation Outcomes using Quantitative Susceptibility Mapping

    A. Roberts, S. Akkus, M. Spadaccia, C. Tozlu, D. Romano, P. Spincemaille, Y. Wang, B. Kopell (Ithaca, USA)

    Objective: To jointly estimate motor and non-motor outcomes of deep brain stimulation using presurgical quantitative susceptibility maps. Background: Parkinson’s disease (PD) patients with motor complications…
  • 2025 International Congress

    Efficacy of Ventral Intermediate Nucleus Deep Brain Stimulation for Head Tremors in Essential Tremor: A Single-Center Retrospective Analysis

    S. Anis, M. Munyeshyaka, J. Hsu, N. Mandava, C. Piccinin, R. Rammo, S. Nagel, H. Fernandez (Cleveland, USA)

    Objective: To evaluate the efficacy of ventral intermediate nucleus (VIM) deep brain stimulation (DBS) in treating head tremors in patients with essential tremor (ET) and…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 169
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley